Framework for the Provision of Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies
This Framework agreement is for the provision of Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies initially for patients of East Midlands Pharmacy Collaborative (EMPC) Member Trusts referred to henceforth as the 'Service' to Participating Purchasing Authorities
Buyer
East Midlands Pharmacy Collaborative
Value
£2,760,000
Published
7 May 2025
Closes
11 Oct 2024
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Open
Category
Services
Contract starts
30 Apr 2025
Contract ends
30 Apr 2027
CPV classifications
85100000
Health services
Lots
Lot default Framework for the Provision of Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies
£2,760,000
This Framework agreement is for the provision of Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies initially for patients of East Midlands Pharmacy Collaborative (EMPC) Member Trusts referred to henceforth as the 'Service' to Participating Purchasing Authorities
Delivery: United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
7 May 2025
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.